Restless Legs Syndrome Treatment and Symptoms trials Restless Legs
Restless legs syndrome (RLS, or Wittmaack-Ekbom's syndrome, which is not to be confused with Ekbom's syndrome) is a poorly understood and often misdiagnosed neurological disorder. Description RLS may be described as uncontrollable urges to move the limbs in order to stop uncomfortable, painful or odd sensations in the body, most commonly in the legs. Moving the affected body part eliminates the sensation, providing temporary relief. The sensations and need to move may return immediately ...
Wikipedia - [full article]
Restless Legs Syndrome Clinical Trials
- Swiss Restless Legs Syndrome Trial (SRLS)
ClinicalTrials.gov Identifier: NCT00144209 - Active, not recruiting
Restless Legs Syndrome
- Restless Legs Syndrome Exercise Intervention
ClinicalTrials.gov Identifier: NCT00258492 - Active, not recruiting
Restless Legs Syndrome; Insomnia; Daytime Sleepiness
- A Study To Look At The Starting Dose Of Ropinirole Immediate Release Tablets In Young Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00140712 - Recruiting
Restless Legs Syndrome
- Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00051961 - Completed
Restless Legs Syndrome
- A Randomized, Double-Blind, Placebo-Controlled Trial with 0.75mg Pramipexole (BI•Sifrol®) Orally Once Daily to Investigate the Efficacy and Safety for 6 Weeks in Patients with Primary Restless Legs Syndrome.
ClinicalTrials.gov Identifier: NCT00152997 - Completed
Restless Legs Syndrome
- A Double-Blind, Placebo-Controlled, Randomised Withdrawal Study of 3 Month Duration in Patients Suffering from Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-Month Treatment with Open-Label Pramipexole Including Titration (0.125, 0.25,
ClinicalTrials.gov Identifier: NCT00152958 - Completed
Restless Legs Syndrome
- Relationship Between Sensory and Motor Systems in Restless Leg Syndrome
ClinicalTrials.gov Identifier: NCT00074672 - Active, not recruiting
Restless Legs Syndrome
- Cross-Sectional Study: Prevalence of Restless Legs Syndrome in Patients With Unpleasant Sensations of the Legs
ClinicalTrials.gov Identifier: NCT00557258 - Active, not recruiting
Restless Legs Syndrome
- A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Trial Comparing Fixed Doses of 0.25 Mg, 0.50 Mg and 0.75 Mg Pramipexole (Mirapex®) Administered Orally to Investigate the Safety and Efficacy in Patients with Idiopathic Restless
ClinicalTrials.gov Identifier: NCT00133198 - Completed
Restless Legs Syndrome
- A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, FIVE-ARM PARALLEL-GROUP TRIAL TO INVESTIGATE THE EFFICACYAND SAFETY OF FOUR DIFFERENT TRANSDERMAL DOSES OF ROTIGOTINE IN SUBJECTS WITH IDIOPATHIC RESTLESS LEGS SYNDROME
ClinicalTrials.gov Identifier: NCT00135993 - Completed
Idiopathic Restless Leg syndrome
- An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00263068 - Active, not recruiting
Restless Legs Syndrome
- Long-Term Study of XP13512 vs. Placebo in Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00311363 - Active, not recruiting
Restless Legs Syndrome
- XP13512 vs. Placebo in Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00365352 - Active, not recruiting
Restless Legs Syndrome
- Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
ClinicalTrials.gov Identifier: NCT00367822 - Active, not recruiting
Restless Legs Syndrome
- Non-Interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life
ClinicalTrials.gov Identifier: NCT00539461 - Active, not recruiting
Restless Legs Syndrome
- Long-Term Study Of Ropinirole In Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00329602 - Recruiting
Restless Legs Syndrome
- XP13512 Extension Study in Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00333359 - Recruiting
Restless Legs Syndrome
- Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00355641 - Recruiting
Restless Legs Syndrome
- The Effects Of Ropinirole On Mood Or Mild Depression In Patients With Moderate To Severe Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00357097 - Recruiting
Moderate to Severe Idiopathic Restless Legs Syndrome (RLS)
- Botulinum Toxin to Treat Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00479154 - Recruiting
Restless Legs Syndrome
- ASP8825 - Study in Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00530530 - Recruiting
Restless Legs Syndrome
- Comprehensive Police Fatigue Management Program
ClinicalTrials.gov Identifier: NCT00246051 - Not yet recruiting
Sleep Disorders; Sleep Apnea, Obstructive; Restless Legs Syndrome; Sleep Disorders, Circadian Rhythm; Sleep Initiation and Maintenance Disorders
- Clinical Evaluation of Ropinirole CR-RLS ( SK&F106064)Tablets in Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00530790 - Not yet recruiting
Restless Legs Syndrome
- SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole
ClinicalTrials.gov Identifier: NCT00344994 - Recruiting
Restless Legs Syndrome
- Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00197080 - Completed
Restless Legs Syndrome
- Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00199446 - Completed
Sleep Disorder; Restless Legs Syndrome
- Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00200941 - Completed
Restless Legs Syndrome
- A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)
ClinicalTrials.gov Identifier: NCT00225862 - Completed
Restless Legs Syndrome
- Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS).
ClinicalTrials.gov Identifier: NCT00239486 - Completed
Restless Legs Syndrome
- A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
ClinicalTrials.gov Identifier: NCT00247364 - Completed
Restless Legs Syndrome
- Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
ClinicalTrials.gov Identifier: NCT00256854 - Completed
Restless Legs Syndrome
- A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00275236 - Completed
Restless Legs Syndrome
- Efficacy and Safety of PPX (Pramipexole) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients
ClinicalTrials.gov Identifier: NCT00275457 - Completed
Restless Legs Syndrome
- XP13512 Versus Placebo in Patients With Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00298623 - Completed
Restless Legs Syndrome
- A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00363857 - Completed
Restless Legs Syndrome
- Sequential Compression Devices for Treatment of Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00479531 - Completed
Restless Legs Syndrome
- Phase 3 Open-Label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
ClinicalTrials.gov Identifier: NCT00498108 - Completed
Idiopathic Restless Legs Syndrome
- 12-Week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
ClinicalTrials.gov Identifier: NCT00373542 - Completed
Restless Legs
- Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food
ClinicalTrials.gov Identifier: NCT00419692 - Completed
Restless Legs Syndrome
- Rotigotine Restless Legs Syndrome Dose Finding Trial
ClinicalTrials.gov Identifier: NCT00243217 - Completed
Idiopathic Restless Leg Syndrome
- Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes
ClinicalTrials.gov Identifier: NCT00004351 - Completed
Williams Syndrome; Angelman Syndrome; Prader-Willi Syndrome; Shprintzen syndrome; Smith-Magenis syndrome; DiGeorge Syndrome; Chromosome Abnormalities
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Proof-of-Concept Trial to Assess the Efficacy, Safety and Tolerability of Ascending Doses of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms in Subjects With Idiopathic Restless
ClinicalTrials.gov Identifier: NCT00389831 - Completed
Idiopathic Restless Legs Syndrome
- Pilot Study of Allogeneic Bone Marrow Transplantation Plus Cyclosporine and Mycophenolate Mofetil to Induce Mixed Hematopoietic Chimerism in Patients With Primary T-Cell Immunodeficiency Disorders
ClinicalTrials.gov Identifier: NCT00008450 - Recruiting
Purine-Pyrimidine Metabolism, Inborn Errors; Wiskott-Aldrich Syndrome; Bare Lymphocyte Syndrome; Lymphopenia; Job's Syndrome; DiGeorge Syndrome; ...
- Sleep Disordered Breathing in Gulf War Syndrome Veterans and the Effect of Continuous Positive Airway Pressure (CPAP) Treatment
ClinicalTrials.gov Identifier: NCT00252629 - Recruiting
Gulf War Syndrome; Chronic Fatigue Syndrome; Functional Somatic Syndrome; Upper Airway Resistance Syndrome; Sleep Apnea
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
ClinicalTrials.gov Identifier: NCT00314860 - Active, not recruiting
Restless Legs Syndrome
- A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS
ClinicalTrials.gov Identifier: NCT00375284 - Active, not recruiting
Restless Legs Syndrome
- A Randomised, Comparing Fixed Doses of Pramipexole to Investigate the Efficacy and Safety in Patients With RLS.
ClinicalTrials.gov Identifier: NCT00390689 - Active, not recruiting
Restless Legs Syndrome
- Long-Term Open-Label Trial in Idiopathic RLS Subjects
ClinicalTrials.gov Identifier: NCT00498186 - Active, not recruiting
Idiopathic Restless Legs Syndrome
- Sleep Disorders Management, Health and Safety in Police
ClinicalTrials.gov Identifier: NCT00207285 - Recruiting
Sleep Disorders; Sleep Apnea, Obstructive; Restless Legs Syndrome; Sleep Disorders, Circadian Rhythm; Sleep Initiation and Maintenance Disorders
- Long-Term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe RLS
ClinicalTrials.gov Identifier: NCT00472199 - Recruiting
Restless Legs Syndrome
- Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
ClinicalTrials.gov Identifier: NCT00006054 - Active, not recruiting
Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; ...
- Amifostine in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003048 - Active, not recruiting
Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome
- Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003984 - Active, not recruiting
Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
- Akathisia (Restless Legs Syndrome) in People with Schizophrenia and Mental Retardation
ClinicalTrials.gov Identifier: NCT00065286 - Completed
Akathisia
- A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS
ClinicalTrials.gov Identifier: NCT00349531 - Completed
Restless Legs Syndrome
- Phase IV Trial With Pramipexole to Evaluate Safety and Efficacy in Patients With RLS Associated With Mood Disturbances
ClinicalTrials.gov Identifier: NCT00356096 - Completed
Restless Legs Syndrome; Depression
- Acitretin in Treating Patients With Skin Disease or Skin Cancer
ClinicalTrials.gov Identifier: NCT00020956 - Active, not recruiting
actinic keratosis; stage III mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; skin metastases; ...
- Amifostine With or Without Epoetin alfa in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003681 - Active, not recruiting
Refractory Anemia; Previously Treated Myelodysplastic Syndrome; Anemia; secondary myelodysplastic syndrome; ...
- Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003790 - Active, not recruiting
Previously Treated Myelodysplastic Syndrome; untreated childhood acute myeloid leukemia; secondary myelodysplastic syndrome; ...
- Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00008151 - Active, not recruiting
Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
- Study of Genetic and Molecular Defects in Primary Immunodeficiency Disorders
ClinicalTrials.gov Identifier: NCT00004341 - Active, not recruiting
X-linked agammaglobulinemia; X-linked hyper IgM syndrome; Wiskott-Aldrich Syndrome; Leukocyte Adhesion Deficiency Syndrome
- Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003959 - Active, not recruiting
Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; ...
- Immunologic Evaluation in Patients With DiGeorge Syndrome or Velocardiofacial Syndrome
ClinicalTrials.gov Identifier: NCT00005102 - Recruiting
DiGeorge Syndrome; Shprintzen syndrome; Chromosome Abnormalities; Abnormalities, Multiple; Conotruncal Cardiac Defects
- Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00074087 - Recruiting
stage II mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; recurrent mycosis fungoides/Sezary syndrome; ...
- Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
ClinicalTrials.gov Identifier: NCT00056056 - Recruiting
stage I mycosis fungoides/Sezary syndrome; stage II mycosis fungoides/Sezary syndrome; recurrent mycosis fungoides/Sezary syndrome
- A Phase 4 Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG Levels in Aldurazyme® (Laronidase) Treated Patients.
ClinicalTrials.gov Identifier: NCT00144768 - Recruiting
Mucopolysaccharidosis I; Hurler''s Syndrome; Hurler-Scheie Syndrome; Scheie Syndrome
- MPS I Registry
ClinicalTrials.gov Identifier: NCT00144794 - Recruiting
Mucopolysaccharidosis I; Hurler''s Syndrome; Hurler-Scheie Syndrome; Scheie Syndrome
- Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003415 - Active, not recruiting
Previously Treated Myelodysplastic Syndrome; de novo myelodysplastic syndrome; refractory anemia with excess blasts in transformation; ...
- Busulfan Compared With Cyclophosphamide in Patients Undergoing Total-Body Irradiation Plus Peripheral Stem Cell Transplantation for Advanced Myelodysplastic Syndrome or Related Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00005866 - Active, not recruiting
untreated adult acute myeloid leukemia; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
- Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00004263 - Active, not recruiting
recurrent adult acute myeloid leukemia; refractory anemia with excess blasts in transformation; Previously Treated Myelodysplastic Syndrome; ...
- Decitabine in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003361 - Active, not recruiting
de novo myelodysplastic syndrome; refractory anemia with excess blasts in transformation; refractory anemia with excess blasts; Refractory Anemia; ...
- Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders
ClinicalTrials.gov Identifier: NCT00006056 - Active, not recruiting
Chediak-Higashi Syndrome; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; ...
- Topotecan in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003675 - Active, not recruiting
Refractory Anemia; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; de novo myelodysplastic syndrome; ...
- Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
ClinicalTrials.gov Identifier: NCT00003662 - Active, not recruiting
Graft Versus Host Disease; Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; ...
- Phase I Study of Vasoactive Intestinal Peptide in Patients with Acute Respiratory Distress Syndrome and Sepsis
ClinicalTrials.gov Identifier: NCT00004494 - Recruiting
Sepsis; Respiratory Distress Syndrome; Respiratory Distress Syndrome, Adult
- Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
ClinicalTrials.gov Identifier: NCT00499317 - Recruiting
Chronic Prostatitis (CP); Chronic Pelvic Pain Syndrome (CPPS); Painful Bladder Syndrome (PBS); Benign Frequency Syndrome (BFS); Benign Daytime Frequency Syndrome (BDFS)
- Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov Identifier: NCT00003171 - Completed
Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; ...
- Genetic Analysis of Fraser Syndrome and Fryns Syndrome
ClinicalTrials.gov Identifier: NCT00032877 - Completed
Fraser Syndrome; Fryns Syndrome; Chromosomal Abnormalities; Abnormalities, Multiple
- Study of Heritable Connective Tissue Disorders
ClinicalTrials.gov Identifier: NCT00001641 - Completed
Connective Tissue Disease; Dissecting Aneurysm; Ehlers Danlos Syndrome; Marfan Syndrome; Nail Patella Syndrome
- A Dose-Optimization Study of Aldurazyme® (Laronidase) in Patients with Mucopolysaccharidosis I (MPS I) Disease
ClinicalTrials.gov Identifier: NCT00144781 - Completed
Mucopolysaccharidosis I; Hurler''s Syndrome; Hurler-Scheie Syndrome; Scheie Syndrome
- Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients
ClinicalTrials.gov Identifier: NCT00146770 - Completed
Mucopolysaccharidosis I; Hurler''s Syndrome; Hurler-Scheie Syndrome; Scheie Syndrome
- Brief Treatment for Temporomandibular Pain
ClinicalTrials.gov Identifier: NCT00067366 - Active, not recruiting
Temporomandibular Joint Syndrome; Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint; Orofacial Pain
- Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00030589 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
- Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
ClinicalTrials.gov Identifier: NCT00003960 - Active, not recruiting
untreated adult acute myeloid leukemia; chronic phase chronic myelogenous leukemia; Previously Treated Myelodysplastic Syndrome; ...
- Genetics of Fibromyalgia
ClinicalTrials.gov Identifier: NCT00071162 - Active, not recruiting
Fibromyalgia; Irritable Bowel Syndrome; Chronic Fatigue Syndrome; Depression
- Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002890 - Active, not recruiting
accelerated phase chronic myelogenous leukemia; Previously Treated Myelodysplastic Syndrome; recurrent adult acute myeloid leukemia; ...
- O(6)-benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-cell Lymphoma
ClinicalTrials.gov Identifier: NCT00003613 - Active, not recruiting
stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
- Retraining Walking after Spinal Cord Injury
ClinicalTrials.gov Identifier: NCT00059553 - Active, not recruiting
Spinal Cord Injuries; Quadriplegia; Paraplegia; Central Cord Syndrome; Brown-Sequard Syndrome
- Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
ClinicalTrials.gov Identifier: NCT00004343 - Active, not recruiting
Cushing's Syndrome
- A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
ClinicalTrials.gov Identifier: NCT00069004 - Active, not recruiting
HIV Infections; HIV-Associated Lipodystrophy Syndrome; HIV Lipodystrophy Syndrome; Lipodystrophy; Dyslipidemia; Osteoporosis; Osteopenia
- IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
ClinicalTrials.gov Identifier: NCT00368173 - Active, not recruiting
Growth Hormone Insensitivity Syndrome (GHIS); Laron Syndrome
- Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
ClinicalTrials.gov Identifier: NCT00001452 - Recruiting
Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
- Genetic Analysis of Immune Disorders
ClinicalTrials.gov Identifier: NCT00001467 - Recruiting
Healthy; Immunologic Deficiency Syndrome; Job's Syndrome; Severe Combined Immunodeficiency
- Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have von Hippel-Lindau Syndrome or Are at Risk for von Hippel-Lindau Syndrome
ClinicalTrials.gov Identifier: NCT00075348 - Recruiting
Renal Cell Cancer; von Hippel-Lindau Syndrome
- Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
ClinicalTrials.gov Identifier: NCT00130286 - Recruiting
HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; Visceral fat accumulation; Fat accumulation; HIV-Associated Metabolic Syndrome
- Sleep Disordered Breathing in Children with Single Ventricle Physiology
ClinicalTrials.gov Identifier: NCT00156455 - Recruiting
Hypoplastic Left Heart Syndrome; Obstructive Sleep Apnea Syndrome; Single Ventricle Phsyiology
- Continuous Positive Airway Pressure in Sleep Apnea Syndrome: Effects on Metabolic Syndrome and Cardiac Damage
ClinicalTrials.gov Identifier: NCT00517777 - Recruiting
Sleep Apnea Syndrome; Metabolic Syndrome; Cardiac Remodelling; Continuous Positive Airway Pressure Ventilation
- 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00003997 - Completed
Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
- Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00003619 - Completed
Polycythemia Vera; Thrombocytopenia; Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; ...
- Leucovorin for the Treatment of 5 q Minus Syndrome
ClinicalTrials.gov Identifier: NCT00004997 - Completed
5q Minus Syndrome; Myelodysplastic Syndrome
Resources
- Brain Basics: Understanding Sleep (National Institute of Neurological Disorders and Stroke, NIH, HHS)
- ClinicalTrials.gov: Restless Legs Syndrome (National Institutes of Health)